THE DIFFERENCES IN PROGNOSTIC OUTCOME BETWEEN AML1/ETO AND CBFβ/MYH11 POSITIVE AML PATIENTS

被引：0
|
作者：
Markova, J. [1 ]
Michkova, P. [1 ]
Maaloufova, J. Soukupova [1 ]
Soukup, P. [1 ]
Cetkovsky, P. [1 ]
Schwarz, J. [1 ]
机构：
[1] Inst Hematol & Blood Transfus, Prague, Czech Republic
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0669
引用
收藏
页码：273 / 274
页数：2
相关论文
共 50 条
  • [1] Prognostic relevance of AML1/ETO and CBFβ/MYH11 molecular rearrangements in AML patients undergoing hematopoietic stem cell transplantation (HSCT) in first remission (CR1).
    Sanz, GF
    López, A
    Barragán, E
    Martín, G
    De la Rubia, J
    Martínez, J
    Jiménez, C
    Jarque, I
    Vicente, A
    Cid, A
    Regadera, A
    Benlloch, L
    Bolufer, P
    Sanz, MA
    BLOOD, 1998, 92 (10) : 205B - 205B
  • [2] Monitoring AML1-ETO and CBFΒ-MYH11 transcripts in acute myeloid leukemia
    John A. Liu Yin
    Lindsay Frost
    Current Oncology Reports, 2003, 5 (5) : 399 - 404
  • [3] Prospective RT-PCR and cytogenetic analysis of 144 new cases of AML to detect PML/RARa, AML1/ETO and CBFβ/MYH11 rearrangements
    Bagshaw, J
    Vickers, SJ
    McMullan, DJ
    Bourn, D
    Waters, JJ
    Griffiths, MJ
    Davison, EV
    JOURNAL OF MEDICAL GENETICS, 1999, 36 : S28 - S28
  • [4] Comparison of karyotype analysis and RT-PCR for AML1/ETO and CBFβ/MYH11 in unselected patients with AML at diagnosis or relapse in a retrospective single center study.
    Mitterbauer, M
    Laczika, K
    Novak, M
    Hilgarth, B
    Pirc-Danoewinata, H
    Haas, OA
    Fonatsch, C
    Lechner, K
    Jaeger, U
    BLOOD, 1998, 92 (10) : 77A - 77A
  • [5] Cytogenetically cryptic rearrangements of AML1/ETO and CBFB/MYH11 in acute myeloid leukemia.
    Bown, NP
    Rowe, D
    Cotterill, SJ
    Ross, FM
    Bunyan, DJ
    Vickers, SJ
    Bryon, J
    McMullan, DJ
    Griffiths, MJ
    Watmore, A
    Reilly, JT
    Vandenberghe, EA
    Wilson, G
    BLOOD, 2000, 96 (11) : 187B - 187B
  • [6] MYH11 and CBFβ gene rearrangement in eight cases of AML
    Voskoboinik, Nadejda
    Iozsef, Dorit
    Sasson, Naama
    Elhasid, Ronit
    Naparstek, Ela
    Orr-Urtreger, Avi
    Rothman, Rachel
    CHROMOSOME RESEARCH, 2013, 21 : S72 - S72
  • [7] Prevalence of PML/RARA, AML1/ETO, CBFB/MYH11 Translocations and Expression Level of Myeloid CD Markers amongst AML Patients of Assam, India
    Nath, S.
    Bhattarcharyya, J.
    Saikia, K. K.
    ANNALS OF HEMATOLOGY, 2015, 94 : S81 - S81
  • [8] Detection and quantification of CBFβ/MYH11 fusion transcripts in inv(16) positive AML patients.
    Krauter, J
    Hoellge, W
    Wattjes, MP
    Nagel, S
    Ganser, A
    Heil, G
    BLOOD, 2000, 96 (11) : 312A - 312A
  • [9] Prevalence of PML/RARA, AML1/ETO, CBFB/MYH11 Translocations and Expression Level of Myeloid CD Markers amongst AML Patients of Assam, India
    Nath, S.
    Bhattarcharyya, J.
    Saikia, K. K.
    ANNALS OF HEMATOLOGY, 2015, 94 (SUPPL 1) : 81 - 81
  • [10] Incidence of cryptic Rearrangements of PML-RARα, CBFβ-MYH11, AML1-ETO and MLL rearrangements in acute myeloid leukemia (AML).
    Klaus, M
    Schnittger, S
    Haferlach, T
    Hiddemann, W
    Schoch, C
    BLOOD, 2001, 98 (11) : 152B - 153B
12345